Article info
Emerging evidence on the use of biological agents in severe asthma
P99 The value of oral prednisolone in patients with severe eosinophilic asthma on mepolizumab treatment
Citation
P99 The value of oral prednisolone in patients with severe eosinophilic asthma on mepolizumab treatment
Publication history
- First published January 21, 2021.
Online issue publication
January 21, 2021
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ.